|
1
|
Kapelari B, Bech-Otschir D, Hegerl R,
Schade R, Dumdey R and Dubiel W: Electron microscopy and
subunit-subunit interaction studies reveal a first architecture of
COP9 signalosome. J Mol Biol. 300:1169–1178. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wei N, Serino G and Deng XW: The COP9
signalosome: More than a protease. Trends Biochem Sci. 33:592–600.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schwechheimer C and Deng XW: COP9
signalosome revisited: A novel mediator of protein degradation.
Trends Cell Biol. 11:420–426. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cope GA, Suh GS, Aravind L, Schwarz SE,
Zipursky SL, Koonin EV and Deshaies RJ: Role of predicted
metalloprotease motif of Jab1/Csn5 in cleavage of Nedd8 from Cul1.
Science. 298:608–611. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wei N and Deng XW: The COP9 signalosome.
Annu Rev Cell Dev Biol. 19:261–286. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Claret FX, Hibi M, Dhut S, Toda T and
Karin M: A new group of conserved coactivators that increase the
specificity of AP-1 transcription factors. Nature. 383:453–457.
1996. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chamovitz DA and Segal D: JAB1/CSN5 and
the COP9 signalosome. A complex situation. EMBO Rep. 2:96–101.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kwok SF, Solano R, Tsuge T, Chamovitz DA,
Ecker JR, Matsui M and Deng XW: Arabidopsis homologs of a c-Jun
coactivator are present both in monomeric form and in the COP9
complex, and their abundance is differentially affected by the
pleiotropic cop/det/fus mutations. Plant Cell. 10:1779–1790. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shackleford TJ and Claret FX: JAB1/CSN5: A
new player in cell cycle control and cancer. Cell Div. 5:262010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Winner M, Koong AC, Rendon BE, Zundel W
and Mitchell RA: Amplification of tumor hypoxic responses by
macrophage migration inhibitory factor-dependent hypoxia-inducible
factor stabilization. Cancer Res. 67:186–193. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Oh W, Lee EW, Sung YH, Yang MR, Ghim J,
Lee HW and Song J: Jab1 induces the cytoplasmic localization and
degradation of p53 in coordination with Hdm2. J Biol Chem.
281:17457–17465. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wan M and Cao X, Wu Y, Bai S, Wu L, Shi X,
Wang N and Cao X: Jab1 antagonizes TGF-beta signaling by inducing
Smad4 degradation. EMBO Rep. 3:171–176. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tomoda K, Kubota Y, Arata Y, Mori S, Maeda
M, Tanaka T, Yoshida M, Yoneda-Kato N and Kato JY: The cytoplasmic
shuttling and subsequent degradation of p27Kip1 mediated by
Jab1/CSN5 and the COP9 signalosome complex. J Biol Chem.
277:2302–2310. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kato JY and Yoneda-Kato N: Mammalian COP9
signalosome. Genes Cells. 14:1209–1225. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hsu MC, Huang CC, Chang HC, Hu TH and Hung
WC: Overexpression of Jab1 in hepatocellular carcinoma and its
inhibition by peroxisome proliferator-activated receptor{gamma}
ligands in vitro and in vivo. Clin Cancer Res. 14:4045–4052. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ahn J, Hong SA, Lee SE, Kim J, Oh YS, Park
SJ and Chung YJ: Cytoplasmic localization of Jab1 and p27 Kip1
might be associated with invasiveness of papillary thyroid
carcinoma. Endocr J. 56:707–713. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu XK, Li Q, Xu LH, Hu LJ, Liao WG, Zhang
XR, Liu ZM, Wu D and Zeng MS: Expression and clinical significance
of SIAH in laryngeal squamous cell carcinoma. Med Oncol.
30:4852013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Boyle P and Ferlay J: Cancer incidence and
mortality in Europe, 2004. Ann Oncol. 16:481–488. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ferlay J, Parkin DM and Steliarova-Foucher
E: Estimates of cancer incidence and mortality in Europe in 2008.
Eur J Cancer. 46:765–781. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li JJ, Yang XM, Wang SH and Tang QL:
Prognostic role of epidermal growth factor-like domain 7 protein
expression in laryngeal squamous cell carcinoma. J Laryngol Otol.
125:1152–1157. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schütz AK, Hennes T, Jumpertz S, Fuchs S
and Bernhagen J: Role of CSN5/JAB1 in Wnt/β-catenin activation in
colorectal cancer cells. FEBS Lett. 586:1645–1651. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee YH, Judge AD, Seo D, Kitade M,
Gómez-Quiroz LE, Ishikawa T, Andersen JB, Kim BK, Marquardt JU,
Raggi C, et al: Molecular targeting of CSN5 in human hepatocellular
carcinoma: A mechanism of therapeutic response. Oncogene.
30:4175–4184. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dong Y, Sui L, Watanabe Y, Yamaguchi F,
Hatano N and Tokuda M: Prognostic significance of Jab1 expression
in laryngeal squamous cell carcinomas. Clin Cancer Res. 11:259–266.
2005.PubMed/NCBI
|
|
25
|
Tomoda K, Kubota Y and Kato J: Degradation
of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by
Jab1. Nature. 398:160–165. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Adler AS, Littlepage LE, Lin M, Kawahara
TL, Wong DJ, Werb Z and Chang HY: CSN5 isopeptidase activity links
COP9 signalosome activation to breast cancer progression. Cancer
Res. 68:506–515. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Thompson CB: Apoptosis in the pathogenesis
and treatment of disease. Science. 267:1456–1462. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Porter AG and Jänicke RU: Emerging roles
of caspase-3 in apoptosis. Cell Death Differ. 6:99–104. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shen Y and White E: p53-dependent
apoptosis pathways. Adv Cancer Res. 82:55–84. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Abu-Qare AW and Abou-Donia MB: Biomarkers
of apoptosis: Release of cytochrome c, activation of caspase-3,
induction of 8-hydroxy-2′-deoxyguanosine, increased
3-nitrotyrosine, and alteration of p53 gene. J Toxicol Environ
Health B Crit Rev. 4:313–332. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cicenas J: The potential role of Akt
phosphorylation in human cancers. Int J Biol Markers. 23:1–9. 2008.
View Article : Google Scholar : PubMed/NCBI
|
